Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Andrology

Free Subscription Articles published in Prostate Retrieve available abstracts of 43 articles: HTML format

Single Articles

June 2025
1. LI Y, Wu Z, Ma J, Liu X, et al
   Zinc Attenuates Prostate Hyperplasia and Inflammatory Injury in Obese Rats by Regulating Zinc Homeostasis and Inhibiting the JAK1/STAT3 Pathway.
   Prostate. 2025;85:767-776.
   PubMed     Abstract available
   
   
   
2. SUN A, Rodriguez-Alvarez JS, Harper S, Khooblall P, et al
   The Prostate Microbiome Is Associated With Prostate Size and PSA Level, Independent of Age, in BPH Patients.
   Prostate. 2025;85:850-859.
   PubMed     Abstract available
   
   
   April 2025
3. PAE S, Sakamoto S, Zhao X, Tamura T, et al
   LHRH Antagonists Restore Serum Testosterone Faster Than LHRH Agonists in Prostate Cancer Patients After Radiotherapy.
   Prostate. 2025 Apr 2. doi: 10.1002/pros.24899.
   PubMed     Abstract available
   
   
   March 2025
4. GUERRA LHA, da Costa Castro NF, Jubilato FC, Marques LA, et al
   Coconut Oil Mitigates the Effects of Aging on the Mongolian Gerbil Prostate.
   Prostate. 2025;85:395-406.
   PubMed     Abstract available
   
   
   February 2025
5. RINGLER R, Gangwish D, Horning P, Kuperus J, et al
   Does size matter? A single institution's comparison of Aquablation in prostates greater than or less than 150 mL.
   Prostate. 2025;85:140-147.
   PubMed     Abstract available
   
   
   
6. ABDELAZIZ AY, Kishk MA, Meshref A, Elfayomy H, et al
   Safety and Efficacy of Intra-Prostatic Injection of Betamethasone for Refractory Chronic Nonbacterial Prostatitis: A Prospective Cohort Clinical Study.
   Prostate. 2025;85:243-251.
   PubMed     Abstract available
   
   
   December 2024
7. KONG X, Dong Z, Hu W, Mi J, et al
   The role of gut microbiota involved in prostate microenvironment and symptoms improvement in chronic prostatitis/chronic pelvic pain syndrome patients treated with low-intensity extracorporeal shock wave.
   Prostate. 2024;84:1525-1536.
   PubMed     Abstract available
   
   
   
8. ALVES BB, Gabrich P, Favorito LA
   Prospective results of the minimally invasive laser enucleation of the prostate (MiLEP).
   Prostate. 2024;84:1501-1505.
   PubMed     Abstract available
   
   
   November 2024
9. WARREN CJ, Payne NG, Edmonds VS, Voleti SS, et al
   Quality of Chatbot Information Related to Benign Prostatic Hyperplasia.
   Prostate. 2024 Nov 8. doi: 10.1002/pros.24814.
   PubMed     Abstract available
   
   
   September 2024
10. JIRASKO M, Vitak R, Pecen L, Pinkeova A, et al
    Serum levels of prostate specific antigen, free PSA, [-2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy.
    Prostate. 2024 Sep 27. doi: 10.1002/pros.24801.
    PubMed     Abstract available
    
    
    
11. ZHANG P, Wang H, Li P, Fu X, et al
    Assessing state-of-the-art online large language models for patient education regarding prostatitis.
    Prostate. 2024;84:1173-1175.
    PubMed    
    
    
    August 2024
12. IGARASHI T, Mizoguchi S, Matsuoka K, Kamijo T, et al
    Effects of oral administration of nonselective Trk inhibitor on bladder overactivity in rodent models of prostatic inflammation.
    Prostate. 2024;84:1016-1024.
    PubMed     Abstract available
    
    
    July 2024
13. LIU TT, Igarashi T, El-Khoury N, Ihejirika N, et al
    Benign prostatic hyperplasia nodules in patients treated with celecoxib and/or finasteride have reduced levels of NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, a mitochondrial protein essential for efficient function of the electron transport
    Prostate. 2024 Jul 14. doi: 10.1002/pros.24766.
    PubMed     Abstract available
    
    
    May 2024
14. ZHANG Y, Zhou J
    Responses to queries concerning "Performance of large language models on benign prostatic hyperplasia frequently asked questions".
    Prostate. 2024 May 16. doi: 10.1002/pros.24748.
    PubMed    
    
    
    
15. DAUNGSUPAWONG H, Wiwanitkit V
    Large language models and benign prostatic hyperplasia frequently asked questions.
    Prostate. 2024 May 16. doi: 10.1002/pros.24719.
    PubMed    
    
    
    
16. HUA X, Zhang J, Chen J, Feng R, et al
    Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO-1 pathway.
    Prostate. 2024;84:666-681.
    PubMed     Abstract available
    
    
    April 2024
17. ABID A, Piperdi H, Babar M, Loloi J, et al
    Minimally invasive surgical therapies for benign prostatic hyperplasia in the geriatric population: A systematic review.
    Prostate. 2024 Apr 24. doi: 10.1002/pros.24717.
    PubMed     Abstract available
    
    
    
18. ROPER C, Slade A, Caras R, Shelton T, et al
    Ejaculatory and erectile function outcomes following holmium laser enucleation of the prostate.
    Prostate. 2024 Apr 1. doi: 10.1002/pros.24697.
    PubMed     Abstract available
    
    
    
19. ZHANG Y, Dong Y, Mei Z, Hou Y, et al
    Performance of large language models on benign prostatic hyperplasia frequently asked questions.
    Prostate. 2024 Apr 1. doi: 10.1002/pros.24699.
    PubMed     Abstract available
    
    
    March 2024
20. ZHAO X, Feng R, Chen J, Jiang Q, et al
    4-Octyl itaconate alleviates experimental autoimmune prostatitis by inhibiting the NLRP3 inflammasome-induced pyroptosis through activating Nrf2/HO-1 pathway.
    Prostate. 2024;84:329-341.
    PubMed     Abstract available
    
    
    February 2024
21. KAMADA S, Sakamoto S, Kinoshita R, Zhao X, et al
    Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix.
    Prostate. 2024 Feb 27. doi: 10.1002/pros.24679.
    PubMed     Abstract available
    
    
    
22. SHIBAMORI K, Kyoda Y, Shindo T, Hashimoto K, et al
    Maternal diet during gestation affect prostatic tissue component in SHR/Izm offspring.
    Prostate. 2024;84:303-314.
    PubMed     Abstract available
    
    
    January 2024
23. CAVANAUGH D, Urbanucci A, Mohamed NE, Tewari AK, et al
    Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS).
    Prostate. 2024 Jan 9. doi: 10.1002/pros.24656.
    PubMed     Abstract available
    
    
    
24. WHITE JA, Kaninjing ET, Adeniji KA, Jibrin P, et al
    Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways.
    Prostate. 2024 Jan 8. doi: 10.1002/pros.24662.
    PubMed     Abstract available
    
    
    
25. JIN R, Forbes CM, Miller NL, Lafin J, et al
    Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance.
    Prostate. 2024 Jan 3. doi: 10.1002/pros.24661.
    PubMed     Abstract available
    
    
    December 2023
26. LEE KS, Yoo JW, Kim DH, Jeon S, et al
    A prospective, randomized, open-label, parallel trial comparing the efficacy of alpha-blocker or 5alpha-reductase inhibitor withdrawal to continued combination therapy on the maintenance of lower urinary tract symptoms in men with benign prostatic hyp
    Prostate. 2023 Dec 27. doi: 10.1002/pros.24663.
    PubMed     Abstract available
    
    
    
27. SCHNEIDER AJ, Serrell EC, Grimes M, Wang S, et al
    Histologic inflammation and collagen content are not positively correlated in human BPH.
    Prostate. 2023;83:1529-1536.
    PubMed     Abstract available
    
    
    November 2023
28. MARIOTTI ACH, Heidrich V, Inoue LT, Coser EM, et al
    Urinary microbiota is associated to clinicopathological features in benign prostatic hyperplasia.
    Prostate. 2023 Nov 13. doi: 10.1002/pros.24649.
    PubMed     Abstract available
    
    
    October 2023
29. DI H, Wen Y
    Vasectomy and risk of prostate cancer: A Mendelian randomization study and confounder analysis.
    Prostate. 2023 Oct 31. doi: 10.1002/pros.24646.
    PubMed     Abstract available
    
    
    
30. ZHOU H, Xu M, Pan Y, Wang S, et al
    The association between several serum micronutrients and benign prostatic hyperplasia: Results from NHANES 2003-2006.
    Prostate. 2023 Oct 29. doi: 10.1002/pros.24641.
    PubMed     Abstract available
    
    
    
31. HATA J, Matsuoka K, Akaihata H, Meguro S, et al
    The activated complement pathway in the fibrous process of benign prostatic hyperplasia.
    Prostate. 2023 Oct 25. doi: 10.1002/pros.24639.
    PubMed     Abstract available
    
    
    
32. ZHANG Y, Peng R, Chen Z, Zhang W, et al
    Evidence for a causal effect of major depressive disorder, anxiety on prostatitis risk: A univariate and multivariate Mendelian randomization study.
    Prostate. 2023;83:1387-1392.
    PubMed     Abstract available
    
    
    
33. WESTHOFEN T, Bensel M, Schlenker B, Becker A, et al
    The impact of previous inguinal mesh hernioplasty on oncological and patient-reported outcomes following radical prostatectomy.
    Prostate. 2023;83:1313-1322.
    PubMed     Abstract available
    
    
    September 2023
34. FUJIWARA S, Kosaka T, Nishimoto Y, Kamisawa K, et al
    Prognostic significance of serum testosterone level in patients with castration-resistant prostate cancer treated with cabazitaxel.
    Prostate. 2023 Sep 3. doi: 10.1002/pros.24620.
    PubMed     Abstract available
    
    
    July 2023
35. LV K, Yang G, Wu Y, Xia X, et al
    The causal effect of metabolic syndrome and its components on benign prostatic hyperplasia: A univariable and multivariable Mendelian randomization study.
    Prostate. 2023 Jul 16. doi: 10.1002/pros.24598.
    PubMed     Abstract available
    
    
    June 2023
36. SEVIM M, Alkis O, Kartal IG, Kazan HO, et al
    Comparison of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain syndrome: A randomized prospective trial.
    Prostate. 2023;83:751-758.
    PubMed     Abstract available
    
    
    
37. LI Z, Lao Y, Bai Y, Li W, et al
    Re: Comparison of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain syndrome: A randomized prospective trial.
    Prostate. 2023;83:896-897.
    PubMed    
    
    
    
38. LEBANI BR, Barcelos ADS, Gouveia DSES, Girotti ME, et al
    The role of transurethral resection of prostate (TURP) in patients with underactive bladder: 12 months follow-up in different grades of detrusor contractility.
    Prostate. 2023;83:857-862.
    PubMed     Abstract available
    
    
    May 2023
39. LEE S, Yoo KH, Kim TS, Cho HJ, et al
    Characteristics of recurrent acute urinary retention in BPH patients in the United States: Retrospective analysis of US-based insurance claims database.
    Prostate. 2023;83:722-728.
    PubMed     Abstract available
    
    
    
40. BABAR M, Loloi J, Tang K, Singh S, et al
    Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: A retrospective study in a multiethnic population.
    Prostate. 2023;83:713-721.
    PubMed     Abstract available
    
    
    April 2023
41. BENGTSEN MB, Heide-Jorgensen U, Borre M, Norgaard M, et al
    Long-term risk of benign prostatic hyperplasia-related surgery and acute urinary retention in men treated with 5-alpha reductase inhibitor versus alpha-blocker monotherapy in routine clinical care.
    Prostate. 2023 Apr 14. doi: 10.1002/pros.24540.
    PubMed     Abstract available
    
    
    March 2023
42. MIYAZAWA Y, Nakamura T, Takezawa Y, Shimizu N, et al
    A prospective study of the relationship between CRPC patient's quality of life after enzalutamide and serum testosterone levels measured via LC-MS/MS.
    Prostate. 2023 Mar 9. doi: 10.1002/pros.24514.
    PubMed     Abstract available
    
    
    February 2023
43. BECK J, Rouleau M, Lemire F, Neveu B, et al
    Mass spectrometry redefines optimal testosterone thresholds in prostate cancer patients undergoing androgen deprivation therapy.
    Prostate. 2023 Feb 27. doi: 10.1002/pros.24501.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Andrology is free of charge.